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implantation site. After 10 months of follow up, the patient is in complete response and side effect of xerostomia and mucositis
presents G1.
http://dx.doi.org/10.1016/j.rpor.2013.03.660
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Introduction. Radiotherapy is an essential part of cervical cancer treatment. The application of endocavitary radiotherapy can
be done with generic or personalized applicators using high or low dose rate or with pulsed radiation. Previously, treatment
prescription was made to point A (ICRU 38), and recently, with the development of 3D brachytherapy planning systems, it’s
prescribed to CTV. We have gone from prescription by points (A and B) using orthogonal radiographic simulation and dose
limiting rectal and bladder points, to prescription to volume (CTV) with simulation using CT/MRI and limiting dose to certain
volumes of organs at risk (bladder, rectum and sigmoid colon).
Objective. To describe the procedure of brachytherapy with Ir192 high dose rate using a in-house Chassagne mould.
Materials and methods. We describe the procedure to make a vaginal mould (with alginate powder) on the 4–5th week of treatment
with external beam radiotherapy. We canalize the endocervical channel with a Cornier cannula, either by direct visualization or
by hysteroscopy in cases where it is not possible to visualize or get through the cervical external os. Then we introduce gauze to
the bottom of the vaginal pouch, and diluted calcium alginate powder. We wait for its solidiﬁcation to remove it and include it
in plaster. This plaster impression is used to make the deﬁnitive acrylic resin mould where 3 channels are carved to make place
for the applicators (2 vaginal and 1 uterine). Later, we perform 5 applications: the ﬁrst one for treatment planning (using CT/RM
and orthogonal radiographs) and, after that, 4 applications of brachytherapy done once a week. Dose prescription is made to the
CTV, administering 7Gy in each session, while the dose constraints used are V6 Gy less than 2cc to the bladder and V5 Gy less
than 2cc of rectum and sigmoid colon.
http://dx.doi.org/10.1016/j.rpor.2013.03.661
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Episcleral brachytherapy is a conservative alternative to enucleation in the treatment of choroidal melanomas and some other
eye injuries as angioma or macular degeneration associated with age. This video describes the process of this technique for the
diagnosis and indication to surgical technique, through dosimetry, indispensable throughout radiotherapy. It also details the
radiation protection standards, as they work with radioactive sources.
http://dx.doi.org/10.1016/j.rpor.2013.03.662
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Purpose. Interstitial brachytherapy is a classic technique in the treatment of oral tongue cancer. Low dose rate brachytherapy
has been used for many years, with good clinical results. Currently, improvement in surgical technique has reduced the number
of available cases in the Radiation Oncology Departments in our country. However, new developments in brachytherapy (HDR
afterloading, computer calculations, CT-based dosimetry) create a good environment to promote this technique for selected
patients. In this educational video we will show the step-by-step technique for interstitial HDR brachytherapy in oral tongue
cancer, with emphasis in the multidisciplinary work. Informed consent was obtained and signed by the patient before recording
the video footage.
Step-by-Step Technique. 1. General anesthesia with naso-tracheal tube. 2. Field cleansing and preparation: using sterile technique
the ﬁeld was prepared and the oral cavity was washed with antiseptic solution. 3. Physical exam: the dimensions of the lesion
were assessed by inspection and palpation. The presence of satellite lesions, leukoplasia and other suspicious lesions was
assessed. The lesion is then delineated with an sterile marker. 4. Clipping of the lesion: sterile markers were inserted with the
help of a hollow needle. Four markers were inserted to help the assessment of the lesion from CT images. 5. Implant planning:
from the previous steps, a previsional ballistics is planned. Needle entry points are marked in the skin of the patient. 6. Implant
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execution: six needles were inserted, to cover the lesion with adequate safety margin to account for microscopic spread. Needles
were planned and inserted according to the rules of the Paris System. 7. Plastic tube overinsertion: plastic tubes were overinserted
into the hollow needles. Needles were then removed and the plastic tubes rested in place. 8. Evaluation of the implant: to assess
if additional tubes are needed for adequate target coverage. 9. Fixation of the tubes with plastic buttons to the skin of the patient.
10. Under the supervision of the anesthesiologist, the patient goes to the CT-room under general anesthesia in order to facilitate
the obtention of CT images to calculate the treatment plan. The patient then goes to the recovery room or ICU according to the
anesthesiologist criteria. 11. Treatment plan is calculated by the medical physicist from CT images. The radiation oncologist
prescribe the dose and accept the plan. 12. After QA procedures are cleared the patient starts treatment.
Conclusion. Interstitial HDR brachytherapy for tongue cancer is a feasible technique. Adequate training is needed to acquire the
needed skills to implement this technique in a general hospital.
http://dx.doi.org/10.1016/j.rpor.2013.03.663
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The risk of developing local recurrence after treatment of a primary rectal cancer increases with increased stage. Treatment of
early-stage rectal cancer with preoperative radiotherapy (RT) and total mesorectal excision result in a local recurrence of 6% for
Stage II and 15% for Stage III tumors. Survival after recurrence depends on stage and treatment and this result in a 3-year survival
rate varying from 0% to 60%. Intraoperative radiotherapy is used to increase dose of Radiation and decrease local recurrence. Two
techniques can be used: intraoperative electron beam radiotherapy (IOERT) and high-dose-rate brachytherapy (HDR-IORT). The
ﬂexible template inHDR-IORT can treat all surfaces. Centers use a 1-cm-thick applicator as a template and often prescribed a dose
of 15Gy at the surface or 10Gy at 0.5 cm depth from the surface of the applicator. The HDR-IORT procedure consists of placing a
ﬂat ﬂexible applicator of a centimeter of thickness, in whose interior there are several placed catheters supporting parallelism
and separation of 1 cm. The applicator is placed in the tumor bed marked with clips, for what is necessary the collaboration of
the surgeons. Later, a 2D planning is realized and patient is translated to the unit of brachytherapy near the operating room.
Our series includes 7 patients treated between 2010 and 2012. Doses: 10Gy to 1 cm of the catheters. Results: pathologic stages:
pT0-mic: 2 p, pT3: 3p, pT4: 2p; distance to the surgical margin: 0–4mm. Failures: local 0p, metastases 2p. Situation at the last
review: 1p death with disease, 1p life with disease, 5p life without disease. In the video we can see a case report of a patient with
locally advanced primary rectal cancer treated with HDR-IORT after preoperative chemoradiotherapy.
http://dx.doi.org/10.1016/j.rpor.2013.03.664
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Introduction. The prostate cancer is themost frequent tumor inmen; the brachytherapy is an alternative treatment highly effective
and tolerable.
Abstract. In May 2011 we have launched LDR brachytherapy technique in our unit, indicated for low risk prostate cancer patients.
Personal: Radiation oncologist, physicist, urologist, anesthetist, nurse, auxiliary nursing and radiation technical. Patient settled
in lithotomy position with spinal anesthesia and urinary catheter.
Procedure. – Positione the endorectal ultrasound image, visualize the prostate in transverse and longitudinal cuts, do the vol-
umetric reconstruction and draw structures (prostate, urethra and rectum). – Perform preplanning dosimetry and check PTV
and OAR dose. – Insert transperineal needles and verify the dosimetric parameters. – Place “seed-selectron”, release the seeds
automatically and remove the needles. – Make cystoscopy to sure that no seeds in bladder and test that there isn’t hematuria.
http://dx.doi.org/10.1016/j.rpor.2013.03.665
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Purpose. Brachytherapy allows delivering higher doses of radiation to more-speciﬁc areas of the body, compared with the conven-
tional form of radiation therapy (external beam radiation). This allows being very effective in tumor control and not damaging
